Official Title
AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience
Brief Summary

The utilization of AlloSure to help guide immunosuppression management in solid organ transplant recipients diagnosed with COVID-19

Detailed Description

An observational case series of patients with solid organ transplants who have been admitted with suspected COVID-19 utilizing AlloSure dd-cf DNA to help guide immunosuppression management balancing the treatment of sepsis and avoiding allograft rejection.

Not yet recruiting
Solid Organ Transplant Rejection
Eligibility Criteria

Inclusion Criteria:

- Liver, Heart, Lung or Kidney organ transplant recipient with a suspected or confirmed diagnosis of COVID-19

Exclusion Criteria:

Eligibility Gender

Alana Burns

NCT Number